STAAR Surgical (STAA) Tops Q3 EPS by 10c, Revenues Beat; 'Raises Outlook for Full Year 2018'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
STAAR Surgical ICL Sales Up 46%; Company Raises Outlook for Full Year 2018
October 31, 2018 4:01 PM EDTMONROVIA, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the third quarter ended September 28, 2018.
Third Quarter 2018 Overview
Net Sales of $31.8 Million Up 35% from the Prior Year Quarter ICL Sales Up 46% and Units Up 56% from the Prior Year Quarter Gross Margin at 75.1% of Sales from 71.8% of Sales in the Prior Year Quarter... More